The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 11, 2020
Filed:
Oct. 20, 2016
Applicant:
Helperby Therapeutics Limited, Greater London, GB;
Inventors:
Anthony Coates, London, GB;
Yanmin Hu, London, GB;
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/4745 (2006.01); A61P 31/06 (2006.01); A61P 31/08 (2006.01); A61K 31/351 (2006.01); A61K 31/7036 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4745 (2013.01); A61K 9/0014 (2013.01); A61K 9/0053 (2013.01); A61K 9/0073 (2013.01); A61K 31/351 (2013.01); A61K 31/7036 (2013.01); A61P 31/06 (2018.01); A61P 31/08 (2018.01); A61K 2300/00 (2013.01); Y02A 50/401 (2018.01); Y02A 50/404 (2018.01); Y02A 50/406 (2018.01); Y02A 50/469 (2018.01); Y02A 50/475 (2018.01); Y02A 50/479 (2018.01); Y02A 50/481 (2018.01); Y02A 50/483 (2018.01);
Abstract
The invention provides a combination comprising 4-methyl-8-phenoxy-1-(2-phenylethyl)-2,3-dihydro-1H-pyrrolo[3,2-c]quinoline or a pharmaceutically acceptable derivative thereof, mupirocin or a pharmaceutically acceptable derivative thereof and neomycin or a pharmaceutically acceptable derivative thereof. This triple combination is particularly useful for the treatment and/or prevention of microbial infections.